Hi!

T2B's Investor Relations Roundtable is adding three new members for Year 2. If you work at the intersection of IR and corporate comms — whether that's your primary focus or part of a broader role — we invite you to consider applying.

About the roundtable

Chaired by Deborah Elson, Senior Director, Corporate Communications and Investor Relations at Tonix Pharmaceuticals, the roundtable is a small working group focused on advancing IR practice across the biopharma industry. Returning members include David Connolly (Rhythm Pharmaceuticals) and Elizabeth Higgins (formerly Astria Therapeutics). Roundtable details here.​

What the group works on

In Year 1, the roundtable tackled real challenges facing IR and communications professionals, from ESG strategy and ratings agencies to how IR priorities shift across market caps. Year 2 builds on those conversations, with a continued focus on:

• Integrating IR into broader corporate affairs strategy
• Communicating effectively with investors and analysts in a volatile market
• Aligning IR planning with data readouts, ESG priorities, and expanding investor audiences

What roundtable members do

This is not an advisory role. Roundtable members are hands-on leaders who:

• Co-create quarterly events and regular resources for the T2B community
• Contribute to roundtable discussions and working sessions
• Help shape how our industry approaches IR

Eligibility

Applicants must hold an active T2B Pro membership and have experience in biopharma IR on the agency, in-house, and/or consulting side.

​Apply by Tuesday, April 21st​

Thanks!

Lynnea